DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Primo Chemicals Limited — Updates

NSE 1 hr ago·16 Sept 2026, 11:53 am

Primo Chemicals

Primo Chemicals has announced that it is acquiring the remaining 51% stake in Flow Tech Chemicals Private Limited. This move will make Flow Tech a wholly-owned subsidiary of Primo Chemicals, allowing the company to consolidate its control over the business.

This acquisition is significant for investors as it expands Primo Chemicals' product portfolio and strengthens its manufacturing capabilities. By integrating Flow Tech, the company aims to enhance its operational efficiency and market position in the chemical sector.

Investors should monitor the completion of this transaction and the subsequent integration of Flow Tech's operations. Any updates regarding synergies or financial performance post-acquisition will be key factors to watch.